In several in vivo assays, it has been reported that EGCG provides antioxidant, anti-inflammatory and antifibrotic protection in different IPF models mainly via activation of the Nrf2 pathway. This evidence concerns the gene NFE2L2 and idiopathic pulmonary fibrosis.